Zheng et al112 examined the CSC‐directing impact of the CSC‐DC vaccine which was combined with a dual suppression of PD‐L1 and CTLA‐4 in an in vivo model for the melanoma tumor. The gene discussed is CTLA4; the disease is neoplasm.